Tesamorelin (10mg)

Inventory Status:

Available

Product Details
AvailabilityIn stock
SKUTESAMORELIN-10MG
SKU TESAMORELIN-10MG Category Brand:

$85.00

Price per mg
Total (10mg)$8.50/mg

Strict Regulatory Notice: This agent is synthesized strictly for laboratory-based research and analytical purposes. It is not intended for human or veterinary use, nor for medical, household, or cosmetic applications. Please review our Terms of Service thoroughly before finalizing your acquisition.

Concentration and Formulation
Contents10mg per vial
FormLyophilized powder

Available

For Research Use Only. Not for human or veterinary use.
Key Documents
SDS = Safety Data Sheet  ·  COA = Certificate of Analysis

Guaranteed Safe Checkout:

payment icons.jpg

Key Specifications

ParameterSpecification / Details
Primary Compound NameTesamorelin (GHRH Analog)
CAS Registry Number218949-48-5
Sequence / IUPACtrans-3-Hexenoyl-GHRH (1-44)
Molecular FormulaC221H366N72O67S
Molar Mass / Weight5135.9 g/mol
Physical AppearanceWhite lyophilized (freeze-dried) solid/powder
Solubility ProfileHighly soluble in Bacteriostatic Water and sterile water.
Tested Purity≥98% via HPLC
Active Ingredient (Total)10mg per vial
Dry / Powder FormulationsLyophilized powder
Storage GuidelinesLyophilized: Store at -20°C for long-term stability. Protect from light.Reconstituted: Must be refrigerated at 2°C to 8°C.
Estimated Shelf Life24 months from manufacture date (lyophilized).
Terms of ApplicationFor laboratory research purposes only. Not for human or veterinary use. Investigated as a stabilized Growth Hormone-Releasing Hormone (GHRH) analog to evaluate basal GH pulsatility, lipid metabolism, and visceral adiposity reduction in cellular and in-vitro models.

Foundational Scientific Overview

Foundational Scientific Overview

Tesamorelin (10mg) is a prominent subject within the field of neuroendocrinology and highly specific lipolytic modeling. Synthesized as a synthetic analogue of growth hormone-releasing factor (GRF) with a trans-3-hexenoic acid moiety, it serves researchers examining the direct stimulation of pituitary somatotrophs and the targeted reduction of visceral adipose tissue in-vitro.

At 4-Amino-Labs, we provide this compound in a highly pure format to ensure experimental reproducibility. By maintaining rigorous measurement standards, we provide the consistency required for longitudinal data integrity.

The biochemical capacity of this modified GRF analog to elevate basal insulin-like growth factor 1 (IGF-1) levels and specifically mobilize visceral fat depots is heavily documented. See: Falutz, J., et al. (2007). "Metabolic effects of a growth hormone-releasing factor in patients with HIV." New England Journal of Medicine, 357(23), 2359-2370.

Analytical Composition and Purity

Purity≥98%via HPLC
FormulaC211H366N72O67S1
Physical StateWhite Lyophilized Solid

Investigational Pathways

Pituitary Agonism
Evaluating the compound’s binding to the GRF receptor, leading to cyclic AMP accumulation and GH transcription.
Visceral Lipolysis
Observing the specific breakdown of triglycerides in cultured adipocytes derived from deep visceral depots.
Hepatic Lipid Clearance
Mapping the reduction of intrahepatic lipid accumulation in metabolic syndrome models.
IGF-1 Elevation
Investigating the downstream synthetic cascades triggered by heightened basal growth hormone levels.

Laboratory Handling and Stability

Thermal Regulation
Store in a controlled, desiccated environment at -20°C for optimal long-term preservation.
Photostability
Protect from direct UV exposure.
Contamination Control
Utilize sterilized instruments and work within a laminar flow hood where possible.

Compliance and Safety

This substance is provided exclusively for in-vitro laboratory research and pre-clinical developmental testing. 4-Amino-Labs does not condone or authorize the use of this product in any clinical setting or for personal consumption. Misuse of laboratory chemicals carries significant health risks. By purchasing, the researcher acknowledges the inherent risks and confirms they possess the necessary equipment and expertise to handle these materials safely.

Analytical Composition & Purity Standards

  • Chemical Formula: C211H366N72O67S1
  • Physical State: White Lyophilized Solid

Our Tesamorelin undergoes a multifaceted verification process. Each batch is subjected to independent High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to ensure a purity threshold of ≥ 98%.

Investigational Pathways

Researchers utilizing Tesamorelin typically focus on the following biochemical mechanisms:

  • Pituitary Agonism: Evaluating the compound’s binding to the GRF receptor, leading to cyclic AMP accumulation and GH transcription.
  • Visceral Lipolysis: Observing the specific breakdown of triglycerides in cultured adipocytes derived from deep visceral depots.
  • Hepatic Lipid Clearance: Mapping the reduction of intrahepatic lipid accumulation in metabolic syndrome models.
  • IGF-1 Elevation: Investigating the downstream synthetic cascades triggered by heightened basal growth hormone levels.

Laboratory Handling & Stability Protocol

To maintain the molecular integrity of Tesamorelin, the following storage parameters are recommended:

  • Thermal Regulation: Store in a controlled, desiccated environment at -20°C for optimal long-term preservation.
  • Photostability: Protect from direct UV exposure.
  • Contamination Control: Utilize sterilized instruments and work within a laminar flow hood where possible.

Compliance & Safety Disclaimer

This substance is provided exclusively for in-vitro laboratory research and pre-clinical developmental testing. 4-Amino-Labs does not condone or authorize the use of this product in any clinical setting or for personal consumption. Misuse of laboratory chemicals carries significant health risks. By purchasing, the researcher acknowledges the inherent risks and confirms they possess the necessary equipment and expertise to handle these materials safely.

0
Please choose an option first.
Tesamorelin (10mg)